Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects
NCT02124278 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2015-04-29
Summary
The purpose is to determine if single doses of PUL-042 inhalation solution are safe in healthy subjects.
Conditions
- Healthy
Interventions
- DRUG
-
PUL-042 Inhalation Solution
Sponsors & Collaborators
-
Pulmotect, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects
NCT04720443 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
NCT06181370 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of Bronchial Segmental Endotoxin Instillation in Humans
NCT02392442 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects
NCT01762878 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers
NCT03691584 ·Status: COMPLETED ·Phase: PHASE1
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
NCT05616221 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers
NCT01661244 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety of Tuberculosis Treatments by Oral Inhalation
NCT01785927 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
NCT04308681 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
NCT06267183 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients
NCT06385964 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
NCT02058407 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled XQ-001 in Healthy Subjects
NCT06918366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis
NCT00205647 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants
NCT06091579 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2
-
NAL ER IPF Respiratory Function and Safety Study
NCT07036029 ·Status: RECRUITING ·Phase: PHASE1
-
A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers
NCT01364519 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers
NCT01314885 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers
NCT00867282 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF
NCT04244825 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.
NCT00862667 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF
NCT02846324 ·Status: COMPLETED ·Phase: PHASE2